A new palm-sized microarray that holds 1,200 individual cultures of fungi or bacteria could enable faster, more efficient drug discovery, according to a study published in mBio®, the online open-access journal of the American Society for Microbiology.
Scientists at the University of Texas at San Antonio and the U.S. Army Institute of Surgical Research at Fort Sam Houston have developed a microarray platform for culturing fungal biofilms, and validated one potential application of the technology to identify new drugs effective against Candida albicans biofilms. The nano-scale platform technology could one day be used for rapid drug discovery for treatment of any number of fungal or bacterial infections, according to the authors, or even as a rapid clinical test to identify antibiotic drugs that will be effective against a particular infection.
“Even though we have used the antifungal concept for development, it is a universal tool,” says co-author Jose Lopez-Ribot of the University of Texas at San Antonio. “It opens a lot of possibilities as a new platform for microbial culture. Any time you need large numbers of cultures, this has a big advantage over other methods.”
“The possibility exists to use this same technology for pretty much any other organism,” he says.
Microbiology and medicine have become increasingly reliant on micro- and nano-scale technologies because of the increased speed and efficiency they can offer, but until now the cultivation of microorganisms has mostly been conducted on larger scales, in flasks and in trays called micro-titer plates. The microarray technology enables the user to rapidly compare hundreds or thousands of individual cultures of bacteria or fungi, a big benefit in the search for new drugs to treat infections. And like many nano-scale techniques, the nano-culture approach described in the mBio® study is also automated, a feature that saves time, improves reproducibility, and prevents some types of user error.
To test the technique, the authors embedded cells of the opportunistic pathogen C. albicans in each of the 1,200 tiny dots of alginate on the surface of the microarray. Under the microscope, these nano-biofilms of C. albicans, each of which was only 30 nanoliters, exhibited the same growth habits and other outward characteristics as conventional, macroscopic biofilms, and achieved maximum metabolic activity within 12 hours. The tiny cultures were then treated with a wide range of candidate drugs from the National Cancer Institute library, or with different FDA-approved, off-patent antifungal drugs in combination with FK506, an immunosuppressant, for identifying individual or synergistic combinations of compounds effective against biofilm infections. Co-author Anand Ramasubramanian of the University of Texas at San Antonio says that the tests prove the utility of the technology in screening combinations of drugs.
“The antifungal screening results were similar to results in larger macroscale techniques. That gives us confidence that it could be used as a tool to replace existing techniques,” says Ramasubramanian.
The Latest Bing News on:
Drug discovery
- Two-punch treatment delivers blood cancer knockout: Study shows drug combo eradicates cancer cells in lab-based testson May 1, 2024 at 6:47 am
The discovery, published in Cancer Cell, could soon lead to clinical trials, providing hope for the 1,100 Australians diagnosed with AML annually. The WEHI research team paired venetoclax, a current ...
- Bloodsucking fly behind ‘new drug discovery’on May 1, 2024 at 12:11 am
Researchers at the University of Sydney have discovered a potentially “game-changing” new drug capable of preventing blood clots and fatal bleeding during surgery – thanks to the bloodsucking African ...
- NYC-based AI drug discovery company moves HQ to Cambridgeon April 30, 2024 at 6:57 am
If you are not in Boston, you are not in biotech, in my opinion,” said the founder of Insilico, a 10-year-old AI drug discovery company that's moving its headquarters from New York to Massachusetts.
- Xaira Launches with $1 Billion to Pioneer AI-Driven Drug Discoveryon April 28, 2024 at 11:36 pm
Xaira Therapeutics, an AI drug discovery startup, recently launched with a remarkable $1 billion funding, backed by prominent investors like ARCH Venture Partners and Foresite Labs. The company, led ...
- A Pharmaceutical Company is Working to Speed Up the Drug Development Process with AIon April 28, 2024 at 9:50 pm
Algorae Pharmaceuticals is finding ways to revamp its process of drug development from cost saving and speed to timeline of drug research and delivery by ...
- Drug Discovery Services Market To Reach USD 75.3 Billion By 2032, Says DataHorizzon Researchon April 27, 2024 at 6:31 am
The drug discovery services market size was valued at USD 20.8 Billion in 2023 and is expected to reach a market size of USD 75.3 Billion by 2032 at a CAGR of 15.4%.Fort Collins, Colorado, April 27, ...
- This Biotech Startup Aims To Speed Up Drug Testing On Animalson April 26, 2024 at 3:29 am
Gordian Biotechnology’s platform allows for potentially hundreds of gene therapies to be tested in an animal at the same time — without harming it.
- A shortcut for drug discovery: Novel method predicts on a large scale how small molecules interact with proteinson April 25, 2024 at 11:00 am
For most human proteins, there are no small molecules known to bind them chemically (so-called "ligands"). Ligands frequently represent important starting points for drug development but this ...
- AI for drug discovery draws a $1 billion launch—and a lot of hopeon April 25, 2024 at 8:20 am
AI's impact on health care is one area where people are more enthusiastic than anxious—and there's reason to think that enthusiasm is not misplaced.
- The Difference Is the Data: Drug Discovery’s AI Revolutionon April 25, 2024 at 4:00 am
New data-intensive platforms continue to leverage artificial intelligence tools for improved speed and failure rate reductions for drug discovery.
The Latest Google Headlines on:
Drug discovery
[google_news title=”” keyword=”drug discovery” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
The Latest Bing News on:
Rapid drug discovery
- Tsetse fly protein provides anticoagulant with its own on-off switchon May 1, 2024 at 7:12 pm
A completely novel way to develop 'surpamolecules' for drug discovery could have application in immunotherapy as well as this breakthrough design for an anticoagulant with on-demand reversibility.
- Rise of Automation in Mass Spectrometry–Based Proteomicson May 1, 2024 at 4:54 pm
Scientists at Harvard Medical School have used technology from Opentrons Labworks to streamline sample preparation.
- Discovery is a potential game-changer in suppressing blood clotson May 1, 2024 at 1:24 pm
The anticoagulant has been developed uses what we call supramolecular chemistry. This allows the two active molecules needed to suppress coagulation to self-assemble.
- 3D Cell Culture Marketon April 28, 2024 at 10:16 pm
D Cell Culture Market an astounding US$ 3 billion by 2033, This trajectory represents a robust Compound Annual Growth Rate (CAGR) of 9%.
- AI is evolving and investors need to change with it. Here’s what to expect.on April 27, 2024 at 4:58 am
Continuous education and advocacy for responsible AI development are essential for both investors and industry stakeholders. Investors should actively engage in discussions surrounding AI ethics, ...
- Solving academic medical centers’ existential crisison April 26, 2024 at 1:30 am
It's a "Sputnik moment" for academical medical centers. Other countries are making large investments in medical research and infrastructure. The U.S. needs to do the same.
- The Difference Is the Data: Drug Discovery’s AI Revolutionon April 25, 2024 at 4:00 am
New data-intensive platforms continue to leverage artificial intelligence tools for improved speed and failure rate reductions for drug discovery.
- Xaira, an AI drug discovery startup, launches with a massive $1B, says it's 'ready' to start developing drugson April 24, 2024 at 7:17 pm
Advances in generative AI have taken the tech world by storm. Biotech investors are making a big bet that similar computational methods could revolutionize drug discovery. On Tuesday, ARCH Venture ...
- A New AI-Driven Drug Discovery Company, Xaira Therapeutics, Launches with $1 Billionon April 24, 2024 at 5:00 pm
Xaira Therapeutics, newly launched with over $1 billion in capital, aims to revolutionize drug discovery using artificial intelligence. The company combines AI with extensive data generation and ...
The Latest Google Headlines on:
Rapid drug discovery
[google_news title=”” keyword=”rapid drug discovery” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]